Business & regional news

Medtronic, a global leader in medical technology, announced today the launch of the new UNiD™ ePRO service in the United States. This solution will change the way patient outcomes are collected...

Annual list highlights organizations leading the way in business integrity

• MEIC is the largest Research and Development (R&D) center outside the US. for Medtronic
• A 250,000 sq. ft. facility devoted to healthcare technology R&D in Hyderabad.

Doubled probe count enables multi-level spine tumor ablations for increased flexibility and efficiency Medtronic plc, a global leader in healthcare technology, today announced that it has received...

Medtronic will unveil the MiniMed™ 780G system with Simplera Sync™, a new disposable, all-in-one sensor.*

Physician feedback confirms clinical evidence: safe, efficient, and effective treatment offers most versatile new option for atrial fibrillation

86% of subjects preferred closed-loop SCS in a multicenter, randomized, crossover, single blind study of Medtronic’s investigational closed-loop SCS system at one month

24-month European RCT data demonstrates long-term superiority of DTM™ SCS compared with conventional medical management (CMM) for indicated chronic back pain patients not eligible for spine surgery

The Schwab Foundation for Social Entrepreneurship, a sister organization of the World Economic Forum (WEF), announced at WEF’s annual meeting in Davos today that Ruchika Singhal, president of Medtronic LABS, is the 2024 “Corporate Social Innovator of the Year.”

Strong environmental, social, and governance (ESG) management and performance result in continued inclusion on the Dow Jones Sustainability World Index

The next-generation DBS technology is now available in a rechargeable option

The PenditureTM Left Atrial Appendage (LAA) Exclusion System is
for the exclusion of the LAA in patients undergoing a concomitant cardiac surgery procedure.

NOVA Study: On-label, prospective, multicenter, randomized controlled trial compared DTM™ SCS to conventional spinal cord stimulation

New guidelines will expand access to automated insulin delivery technology among wider population.

Next-Gen Evolut FX TAVI system enhances procedure ease-of-use, visualization, and predictability

Data shows the successful performance of the AID algorithm under substantial changes to daily routines and lifestyle, including during Ramadan.

The company will initiate a phased launch of its disposable Simplera^TM CGM at the meeting, its smallest and most comfortable CGM to-date that’s integrated with the InPen^TM smart insulin pen

• Improved survival with ICD therapy: nearly 25% lower risk of death in indicated patients receiving an ICD vs. no ICD
• ICDs confer additional long-term benefits after initial device replacement

Newly released guidance affirms safety in use of paclitaxel-coated medical devices in treatment of PAD

An additional 11 million Medicare beneficiaries will now have access to coverage for spinal cord stimulation therapy for the treatment of painful diabetic peripheral neuropathy

Orders will be processed immediately and shipments will start in the coming weeks

Results show that the use of InPen resulted in an increase in Time in Range among those in the studies ​

SCAI 2023 Scientific Sessions: Harmony™ Transcatheter Pulmonary Valve System Demonstrates Strong Clinical and Hemodynamic Outcomes at Two Years

Heart Rhythm 2023: Late-breaking analysis of the PULSED AF Trial reveals first of its kind significant, meaningful quality of life improvements and healthcare utilization benefits of the PulseSelect Pulsed Field Ablation System

12-month results reinforce versatility and durability for the treatment of paroxysmal and persistent AFib with the first-of-its-kind pulsed field ablation, radiofrequency, and high density mapping Sphere-9™ Catheter

MRI Care Pathway can increase flexibility and efficiency with new tools developed to streamline workflow

ACC.23/WCC Late-Breaking Clinical Trial: Evolut™ is only TAVR to show excellent outcomes in low-risk patients at 3 years

CRT 2023 Late-Breaking Data: CoreValve/Evolut™ platform demonstrates significantly lower bioprosthetic valve dysfunction compared to surgery at five years

Harmony™ Transcatheter Pulmonary Valve System is the first FDA-approved minimally invasive valve designed for the right side of the heart

ADVANCE Trial compares sac regression in the Medtronic Endurant™ II/IIs stent graft system and the Gore® Excluder®* AAA Device Family systems

London Valves 2022: Latest Transcatheter Aortic Valve Replacement Data for Treatment of Aortic Stenosis and Prosthetic Aortic Valve Degeneration

Late-breaking clinical presentations at VIVA show IN.PACT™ Admiral™ drug-coated PTA balloon catheter outperforms bare metal stents; maintains performance in real-world setting

Study data show clinically meaningful impact on quality of life and disease severity, even in the most complex patients

-- Nexpowder™* provides gastroenterologists improved visibility, controls upper gastrointestinal (GI) bleeding effectively and with ease^1,2,3 --

-- Nexpowder™* endoscopic hemostasis system showed a lower rebleeding rate and has nearly double the adhesive force of other hemostatic sprays^2,3 --

TCT 2022: Late-breaking data from Intrepid™ Pilot Study 3-year follow-up & 1-year follow-up from Transfemoral EFS study demonstrate promising valve performance Medtronic today announced new data...

TCT 2022: Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets Medtronic today announced findings from its Pathological Study of Hypo-Attenuated...

TCT 2022: Medtronic Unveils Latest Transcatheter Aortic Valve Replacement Data in Late-Breaking Clinical Science and Presentations

Mid-term results of Optimize PRO clinical study reinforces benefits of predictability and control using cusp overlap technique

EXPAND TAVR II Pivotal Trial evaluating the Evolut™ TAVR platform in a new patient population

Medtronic, the global leader in medical technology, today announced new randomized controlled data demonstrating the sustained and superior performance of IN.PACT AV drug coated balloon (DCB)...

ACC.22: Late-breaking data show CoreValve™ and Evolut™ is the only platform to out-perform surgery in valve durability at five years